Daniel C. Chan
Impact in
- Oncology top 2%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
-
- Silymarin and Mushroom Poisoning
- Lung Cancer Treatments and Mutations
Papers in
-
- Enzyme function and inhibition 6
- Cancer therapeutics and mechanisms 6
- Oncology 25
- Peptidase Inhibition and Analysis 11
- Co-authors
- Paul A. Bunn (32 shared papers)Rajesh Agarwal (9 shared papers)Rana P. Singh (6 shared papers)Chapla Agarwal (6 shared papers)Anil K. Tyagi (4 shared papers)Barbara A. Helfrich (15 shared papers)Dmitri B. Kirpotin (2 shared papers)Anna E. Barón (7 shared papers)
- Journals
- Clinical Cancer Research (6 papers)Cancer Research (5 papers)Canadian Journal of Physiology and Pharmacology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- United StatesJapanPoland
In The Last Decade
Daniel C. Chan
80 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 122
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 2.6k
- Cancer Research 508
- Genetics 353
Countries citing papers authored by Daniel C. Chan
This map shows the geographic impact of Daniel C. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Chan more than expected).
Fields of papers citing papers by Daniel C. Chan
This network shows the impact of papers produced by Daniel C. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Chan. The network helps show where Daniel C. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel C. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 422 | |
| 2 | Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. | 2002 | 283 |
| 3 | 2003 | 243 | |
| 4 | 1993 | 233 | |
| 5 | 2005 | 194 | |
| 6 | Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. | 2002 | 169 |
| 7 | Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. | 1999 | 165 |
| 8 | 2004 | 133 | |
| 9 | 2005 | 131 | |
| 10 | Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. | 2001 | 131 |
| 11 | 2002 | 125 | |
| 12 | 2004 | 124 | |
| 13 | 2004 | 114 | |
| 14 | 2006 | 112 | |
| 15 | 2006 | 111 | |
| 16 | 2012 | 109 | |
| 17 | 2004 | 107 | |
| 18 | 2003 | 98 | |
| 19 | Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. | 2003 | 92 |
| 20 | Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. | 1996 | 88 |
About Daniel C. Chan
Daniel C. Chan is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Pharmacology, having authored 81 papers that have together received 5.1k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Peptidase Inhibition and Analysis (11 papers), Lung Cancer Treatments and Mutations (7 papers), Neuropeptides and Animal Physiology (7 papers), Silymarin and Mushroom Poisoning (6 papers), Inflammatory mediators and NSAID effects (6 papers), Enzyme function and inhibition (6 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.2k citations), Molecular Biology (2.6k citations), Cancer Research (508 citations) and Genetics (353 citations). Daniel C. Chan has collaborated with scholars based in United States, Japan and Poland. Frequent co-authors include Paul A. Bunn, Rajesh Agarwal, Rana P. Singh, Chapla Agarwal, Anil K. Tyagi, Barbara A. Helfrich, Dmitri B. Kirpotin, Anna E. Barón, Wilbur A. Franklin and B. Helfrich. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Canadian Journal of Physiology and Pharmacology, Proceedings of the National Academy of Sciences and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.